GWAS |
- 3-month functional outcome in ischaemic stroke (modified Rankin score) ( 30796134)
- Attention deficit hyperactivity disorder ( 30563984)
- Body mass index ( 26426971)
- Corneal astigmatism ( 29422769)
- Disease progression to choroidal neovascularization form in age-related macular degeneration ( 29346644)
- Liver fibrosis in non-alcoholic fatty liver disease ( 31311600)
- Sleep (1/2-day periodicity) ( 33075057)
- Telomere length ( 30185882)
- Testosterone levels x fluid intelligence interaction ( 33407712)
- Tonometry ( 17903302)
|
- Antidepressant treatment resistance (> 2 drugs prescribed) ( 30700811)
- Blood protein levels ( 30072576)
- Body mass index ( 26426971)
- Cerebral amyloid deposition in APOEe4 non-carriers (PET imaging) ( 26252872)
- Dementia and core Alzheimer's disease neuropathologic changes ( 25188341)
- Metabolite levels (X-11787) ( 23934736)
- Motion sickness ( 25628336)
- Parkinson's disease or first degree relation to individual with Parkinson's disease ( 31701892)
- Pneumoconiosis in silica exposure ( 24986923)
- Protein quantitative trait loci ( 18464913)
|